Ilan  Danieli net worth and biography

Ilan Danieli Biography and Net Worth

CEO of Precipio
Ilan Danieli has served as Precipio's CEO since founding the company in early 2011. With over 20 years managing small and medium-size companies, some of his previous experiences include COO of Osiris, a publicly-traded company based in New York City with operations in the US, Canada, Europe and Capital Management, a multi-billion dollar hedge fund; and in various other entrepreneurial ventures. Ilan holds an MBA from the Darden School at the University of Virginia, and a BA in Economics from Bar-Ilan University in Israel.

What is Ilan Danieli's net worth?

The estimated net worth of Ilan Danieli is at least $15,030.04 as of January 3rd, 2023. Mr. Danieli owns 2,852 shares of Precipio stock worth more than $15,030 as of December 22nd. This net worth approximation does not reflect any other investments that Mr. Danieli may own. Additionally, Mr. Danieli receives an annual salary of $325,060.00 as CEO at Precipio. Learn More about Ilan Danieli's net worth.

How old is Ilan Danieli?

Mr. Danieli is currently 52 years old. There are 3 older executives and no younger executives at Precipio. Learn More on Ilan Danieli's age.

What is Ilan Danieli's salary?

As the CEO of Precipio, Inc., Mr. Danieli earns $325,060.00 per year. Learn More on Ilan Danieli's salary.

How do I contact Ilan Danieli?

The corporate mailing address for Mr. Danieli and other Precipio executives is 4 Science Park, New Haven CT, 06511. Precipio can also be reached via phone at (203) 787-7888 and via email at [email protected]. Learn More on Ilan Danieli's contact information.

Has Ilan Danieli been buying or selling shares of Precipio?

Ilan Danieli has not been actively trading shares of Precipio in the last ninety days. Most recently, on Tuesday, January 3rd, Ilan Danieli bought 825 shares of Precipio stock. The stock was acquired at an average cost of $12.00 per share, with a total value of $9,900.00. Following the completion of the transaction, the chief executive officer now directly owns 2,852 shares of the company's stock, valued at $34,224. Learn More on Ilan Danieli's trading history.

Who are Precipio's active insiders?

Precipio's insider roster includes David Cohen (Director), Ilan Danieli (CEO), and Ahmed Sabet (COO). Learn More on Precipio's active insiders.

Are insiders buying or selling shares of Precipio?

In the last year, insiders at the biotechnology company sold shares 1 times. They sold a total of 2,000 shares worth more than $12,560.00. The most recent insider tranaction occured on November, 11th when Director Richard A Sandberg sold 2,000 shares worth more than $12,560.00. Insiders at Precipio own 13.3% of the company. Learn More about insider trades at Precipio.

Information on this page was last updated on 11/11/2024.

Ilan Danieli Insider Trading History at Precipio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/3/2023Buy825$12.00$9,900.002,852View SEC Filing Icon  
10/3/2022Buy550$17.40$9,570.002,027View SEC Filing Icon  
12/1/2021Buy128$37.80$4,838.40View SEC Filing Icon  
9/7/2021Buy74$67.20$4,972.80View SEC Filing Icon  
6/1/2021Buy37$67.40$2,493.801,110View SEC Filing Icon  
12/1/2020Buy55$44.60$2,453.001,021View SEC Filing Icon  
9/1/2020Buy57$43.00$2,451.00966View SEC Filing Icon  
7/6/2020Buy129$19.20$2,476.80908View SEC Filing Icon  
12/2/2019Buy58$41.80$2,424.40702View SEC Filing Icon  
6/7/2019Buy29$84.40$2,447.60View SEC Filing Icon  
See Full Table

Ilan Danieli Buying and Selling Activity at Precipio

This chart shows Ilan Danieli's buying and selling at Precipio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Precipio Company Overview

Precipio logo
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
Read More

Today's Range

Now: $5.27
Low: $5.22
High: $5.46

50 Day Range

MA: $6.12
Low: $5.27
High: $6.65

2 Week Range

Now: $5.27
Low: $4.31
High: $7.30

Volume

2,600 shs

Average Volume

7,182 shs

Market Capitalization

$7.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4